Advertisement

Jansen Jab Gets The EMA’s Go Ahead

The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the...

Share this article

09.41 21 Apr 2021


Jansen Jab Gets The EMA’s Go Ahead


Listen to this episode


Share this article

09.41 21 Apr 2021


The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the European Medicines Agency concluded yesterday. Concerns about the Jansen jab’s safety had been raised following reports of a small number of blood clots in US recipients. Professor of Experimental Immunology at Trinity College Dublin, Kingston Mills joined us this morning.

Listen and subscribe to Newstalk Breakfast on Apple Podcasts or Spotify.

   

Download, listen and subscribe on the Newstalk App.

  

You can also listen to Newstalk live on newstalk.com or on Alexa, by adding the Newstalk skill and asking: 'Alexa, play Newstalk'.


Read more about

Breakfast Covid Vaccine Jansen Vaccine Johnson And Johnson Newstalk Newstalk Breakfast Vaccine

Related Episodes

OFF THE BALL BREAKFAST: Perfor...

02:17:58

OFF THE BALL BREAKFAST: Performance Rankings, Jonathan Wilson on Arsenal’s FA Cup Exit, Quinlan on Leinster & Munster, Tommy Rooney on GAA Action

OTB Breakfast

02:17:58


M&S Report: Nutrition &...

00:09:01

M&S Report: Nutrition & Brain Health Experts

Alive And Kicking With Clare McKenna

00:09:01


Is football better without VAR...

00:25:48

Is football better without VAR? | Arsenal need a goalscorer | Jonathan Wilson | OTB Breakfast Soccer

OTB Football

00:25:48


Government formation talks ram...

00:09:12

Government formation talks ramp up!

Newstalk Breakfast Highlights

00:09:12